SERIES H COMMON STOCK PURCHASE WARRANTGeoVax Labs, Inc. • December 28th, 2018 • Services-commercial physical & biological research
THIS SERIES H COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Sabby Healthcare Master Fund, Ltd or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 27, 2019 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the 30 month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from GeoVax Labs, Inc., a Delaware corporation (the “Company”), up to _________________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • December 28th, 2018 • GeoVax Labs, Inc. • Services-commercial physical & biological research
This Additional Issuance Agreement (this “Agreement”), dated as of December 27, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of March 5, 2018 (the “Purchase Agreement”), as amended, by and between GeoVax Labs, Inc. (the “Company”) and the purchasers signatory hereto (the “Purchaser”) for the purchase of the promissory notes (the “Promissory Notes”) and Common Stock Purchase Warrants (“New Warrants”, and together with the Promissory Notes, the “Additional Securities”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
GEOVAX LABS, INC. Term Promissory NoteGeoVax Labs, Inc. • December 28th, 2018 • Services-commercial physical & biological research • New York
FOR VALUE RECEIVED, the undersigned, Geovax Labs, Inc. (the “Borrower”), promises to pay to the order of Sabby Volatility Warrant Master Fund, Ltd., its successors or assigns (the “Holder”), $__________ (the “Face Amount”) by January 22, 2019 (the “Maturity Date”) or as otherwise provided in accordance with the terms of this Term Promissory Note (the “Note”), together with accrued but unpaid interest, as provided herein.
